Correlation Between Nutra Pharma and Elixinol Global

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Nutra Pharma and Elixinol Global at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nutra Pharma and Elixinol Global into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nutra Pharma Corp and Elixinol Global, you can compare the effects of market volatilities on Nutra Pharma and Elixinol Global and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nutra Pharma with a short position of Elixinol Global. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nutra Pharma and Elixinol Global.

Diversification Opportunities for Nutra Pharma and Elixinol Global

0.27
  Correlation Coefficient

Modest diversification

The 3 months correlation between Nutra and Elixinol is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding Nutra Pharma Corp and Elixinol Global in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Elixinol Global and Nutra Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nutra Pharma Corp are associated (or correlated) with Elixinol Global. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Elixinol Global has no effect on the direction of Nutra Pharma i.e., Nutra Pharma and Elixinol Global go up and down completely randomly.

Pair Corralation between Nutra Pharma and Elixinol Global

Given the investment horizon of 90 days Nutra Pharma Corp is expected to generate 2.49 times more return on investment than Elixinol Global. However, Nutra Pharma is 2.49 times more volatile than Elixinol Global. It trades about 0.21 of its potential returns per unit of risk. Elixinol Global is currently generating about 0.2 per unit of risk. If you would invest  0.01  in Nutra Pharma Corp on September 3, 2025 and sell it today you would earn a total of  0.04  from holding Nutra Pharma Corp or generate 400.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy47.62%
ValuesDaily Returns

Nutra Pharma Corp  vs.  Elixinol Global

 Performance 
       Timeline  
Nutra Pharma Corp 

Risk-Adjusted Performance

Solid

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Nutra Pharma Corp are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. In spite of rather fragile technical indicators, Nutra Pharma exhibited solid returns over the last few months and may actually be approaching a breakup point.
Elixinol Global 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Elixinol Global are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Elixinol Global reported solid returns over the last few months and may actually be approaching a breakup point.

Nutra Pharma and Elixinol Global Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Nutra Pharma and Elixinol Global

The main advantage of trading using opposite Nutra Pharma and Elixinol Global positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nutra Pharma position performs unexpectedly, Elixinol Global can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elixinol Global will offset losses from the drop in Elixinol Global's long position.
The idea behind Nutra Pharma Corp and Elixinol Global pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Other Complementary Tools

Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.